- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03874923
Comparison of 250 ml Versus 500 ml of Fluid Challenge (KOBIAS)
May 16, 2023 updated by: Centre Hospitalier Universitaire, Amiens
Comparison of 250 ml Versus 500 ml of Fluid Challenge on Oxygen Consumption in Critical Care Patients: an Open Label Multicentre Prospective Study
The objective of fluid challenge is to increase oxygen delivery (DO2) in order to improve/restore tissue oxygen consumption (VO2).
However the fluid challenge volume to administer stills in debate, some studies recommend to administer 250 mL.
Previous studies suggested that 500 mL of fluid challenge administration may improve cardiac output and oxygen delivery.
The relation between the amount of fluid expansion and oxygen delivery and oxygen consumption was not yet been studied in a randomized study in critical care patients.
This is the purpose of this study.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Amiens, France
- CHU Amiens Picardie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patient for whom the physician in charge decided to infuse fluid challenge because of signs of acute circulatory failure (systolic arterial blood pressure < 90mmHg, and/or mean arterial blood pressure< 65 mmHg, and/or the need of vasopressive amine infusion, and/or skin mottling, and/or diuresis <0.5 mL/kg/h for more than 2 hours, and/or arterial lactate level>2mmol/L.
- Echogenic patient
- Patient with a Stroke Volume (SV) variation with passive leg raising (PLR) more than 10%.
- Patient with regular sinus rhythm.
- Patient who received protocol information.
Exclusion Criteria:
- Age Under 18-year-old.
- Pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: 250 mL of fluid challenge
|
After randomisation, patient will receive 250 ml or 500 ml of fluid challenge.
VO2 will be assessed before fluid challenge, immediately, 30 minutes and 60 minutes after fluid challenge.
|
Experimental: 500 mL of fluid challenge
|
After randomisation, patient will receive 250 ml or 500 ml of fluid challenge.
VO2 will be assessed before fluid challenge, immediately, 30 minutes and 60 minutes after fluid challenge.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VO2 after fluid challenge
Time Frame: 30 minutes after fluid challenge.
|
Tissue oxygen consumption (VO2) after fluid challenge
|
30 minutes after fluid challenge.
|
VO2 after fluid challenge
Time Frame: 60 minutes after fluid challenge.
|
Tissue oxygen consumption (VO2) after fluid challenge
|
60 minutes after fluid challenge.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of arterial lactate concentration from baseline
Time Frame: 30 minutes after fluid challenge.
|
Baseline is the measurement of arterial lactate concentration immediately after fluid challenge
|
30 minutes after fluid challenge.
|
Change of arterial lactate concentration from baseline
Time Frame: 60 minutes after fluid challenge.
|
Baseline is the measurement of arterial lactate concentration immediately after fluid challenge
|
60 minutes after fluid challenge.
|
Respiratory variation of stroke volume
Time Frame: Immediately, 30 and 60 minutes after fluid challenge.
|
Respiratory variation of stroke volume after fluid challenge.
|
Immediately, 30 and 60 minutes after fluid challenge.
|
PaO2/FiO2
Time Frame: Immediately, 30 and 60 minutes after fluid challenge.
|
PaO2/FiO2 ratio (ratio of arterial oxygen partial pressure to fractional inspired oxygen) after fluid challenge
|
Immediately, 30 and 60 minutes after fluid challenge.
|
Respiratory variation of the pulse pressure
Time Frame: 30 and 60 minutes after fluid challenge.
|
Respiratory variation of the pulse pressure
|
30 and 60 minutes after fluid challenge.
|
Stroke volume variation with passive leg raising (PLV)
Time Frame: 30 and 60 minutes after fluid challenge.
|
Stroke volume variation with passive leg raising (PLV)
|
30 and 60 minutes after fluid challenge.
|
Systolic heart function (LVEF)
Time Frame: Immediately, 30 and 60 minutes after fluid challenge.
|
Systolic heart function (LVEF)
|
Immediately, 30 and 60 minutes after fluid challenge.
|
Diastolic heart function
Time Frame: Immediately, 30 and 60 minutes after fluid challenge.
|
Diastolic heart function (E, A, E', A', S' waves)
|
Immediately, 30 and 60 minutes after fluid challenge.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Osama Abou-Arab, Dr, CHU Amiens
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Actual)
May 24, 2021
Study Completion (Anticipated)
August 1, 2023
Study Registration Dates
First Submitted
March 7, 2019
First Submitted That Met QC Criteria
March 12, 2019
First Posted (Actual)
March 14, 2019
Study Record Updates
Last Update Posted (Actual)
May 17, 2023
Last Update Submitted That Met QC Criteria
May 16, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- PI2018_843_0034
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Oxygen Consumption
-
University of Wisconsin, MadisonRecruitingOxygen ConsumptionUnited States
-
Sackner Wellness Products LLCCompleted
-
The Swedish School of Sport and Health SciencesSilicon Valley Exercise Analytics (svexa)RecruitingPhysical Performance | Maximal Oxygen ConsumptionSweden
-
Concordia University, MontrealCompletedBlood Flow | Oxygen Consumption | Mitochondria | Aerobic CapacityCanada
-
Izmir Katip Celebi UniversityCompletedOxygen Consumption | Red Blood Cell TransfusionTurkey
-
Maíra F PessoaCompleted
-
Boston Children's HospitalRecruitingOxygen Consumption | Mechanical Ventilation | Metabolism | Calorimetry, IndirectUnited States
-
University of LiegeEnrolling by invitationWounds and Injuries | Running | Oxygen ConsumptionBelgium
-
VIA University CollegeCompleted
-
University Hospital Plymouth NHS TrustCompletedPost-operative Complications | Oxygen Consumption (V̇O2) | Oxygen Delivery (DO2)United Kingdom
Clinical Trials on Fluid challenge
-
University Hospital Hradec KraloveUniversity Hospital PilsenCompletedSepsis | Septic Shock | Surgery | Endothelial Dysfunction | AnesthesiaCzechia
-
Pontificia Universidad Catolica de ChileFondo Nacional de Desarrollo Científico y Tecnológico, ChileNot yet recruiting
-
Humanitas Clinical and Research CenterCompletedAnesthesia, General | Cardiovascular System | NeurosurgeryItaly
-
Central Hospital, Nancy, FranceUnknownShock, Septic | Aortic Stenosis | Oliguria | Aortic Aneurysm, Abdominal | Hyperlactatemia | Aortic Aneurysm, RupturedFrance
-
University Medical Center GroningenCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustSuspendedMyocardial Infarction | Coronary Artery Disease | Heart Failure | Pulmonary HypertensionUnited Kingdom
-
Humanitas Clinical and Research CenterRecruitingCritically Ill Patients | Hemodynamic Instability | Mechanical Ventilation Pressure HighItaly
-
Ain Shams UniversityActive, not recruiting
-
St George's Healthcare NHS TrustUnknownPeri-operative Fluid Management